|
2IGQ
Human euchromatic histone methyltransferase 1
提交 2006-09-23
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
951–1235(285 aa)
片段:C-terminal domain, residues 951-1235
链 B
951–1235(285 aa)
片段:C-terminal domain, residues 951-1235
|
未记录
|
ZN ZINC ION × 8
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;300 K;20% PEG 4K, 10% Isoproponol, 0.1M Hepes 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 2.00 Å
R-free 0.237
|
|
2RFI
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and dimethylated H3K9 peptide
提交 2007-09-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
951–1235(285 aa)
片段:Catalytic domain: Residues 951-1235
|
未记录
|
ZN ZINC ION × 4
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 9;300 K;16% PEG 4000, 10% Isopropanol, 0.1M Bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.59 Å
R-free 0.220
|
|
2RFI
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and dimethylated H3K9 peptide
提交 2007-09-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
951–1235(285 aa)
片段:Catalytic domain: Residues 951-1235
|
未记录
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 9;300 K;16% PEG 4000, 10% Isopropanol, 0.1M Bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.59 Å
R-free 0.220
|
|
2RFI
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and dimethylated H3K9 peptide
提交 2007-09-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 A
951–1235(285 aa)
片段:Catalytic domain: Residues 951-1235
链 B
951–1235(285 aa)
片段:Catalytic domain: Residues 951-1235
|
未记录
|
ZN ZINC ION × 8
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 9;300 K;16% PEG 4000, 10% Isopropanol, 0.1M Bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.59 Å
R-free 0.220
|
|
3B7B
EuHMT1 (Glp) Ankyrin Repeat Domain (Structure 1)
提交 2007-10-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
734–968(235 aa)
片段:Ankyrin repeat domains 2-7
|
未记录
|
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;289 K;1.5-2.0 M Lithium Sulfate, 1-4% Peg 400 or 550, 0.1 M Tris buffer pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
分辨率 2.99 Å
R-free 0.261
|
|
3B7B
EuHMT1 (Glp) Ankyrin Repeat Domain (Structure 1)
提交 2007-10-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
734–968(235 aa)
片段:Ankyrin repeat domains 2-7
|
未记录
|
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;289 K;1.5-2.0 M Lithium Sulfate, 1-4% Peg 400 or 550, 0.1 M Tris buffer pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K
|
分辨率 2.99 Å
R-free 0.261
|
|
3FPD
G9a-like protein lysine methyltransferase inhibition by BIX-01294
提交 2009-01-05
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
975–1235(261 aa)
片段:UNP residues 975-1235, SET domain
链 B
975–1235(261 aa)
片段:UNP residues 975-1235, SET domain
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
Q4A N-(1-benzylpiperidin-4-yl)-6,7-dimethoxy-2-(4-methyl-1,4-diazepan-1-yl)quinazolin-4-amine × 2
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 7.5;289 K;0.1 M HEPES pH 7.5, 18-20 % polyethylene glycol 4000 and 7-10 % isopropanol, in the absence or presence of DMSO (6-36%), VAPOR DIFFUSION, temperature 289K
|
分辨率 2.40 Å
R-free 0.262
|
|
3HNA
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and mono-Methylated H3K9 Peptide
提交 2009-05-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
951–1235(285 aa)
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6;300 K;20%PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.50 Å
R-free 0.193
|
|
3HNA
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and mono-Methylated H3K9 Peptide
提交 2009-05-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
951–1235(285 aa)
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6;300 K;20%PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.50 Å
R-free 0.193
|
|
3HNA
Crystal structure of catalytic domain of human euchromatic histone methyltransferase 1 in complex with SAH and mono-Methylated H3K9 Peptide
提交 2009-05-30
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 A
951–1235(285 aa)
链 B
951–1235(285 aa)
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6;300 K;20%PEG3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
分辨率 1.50 Å
R-free 0.193
|
|
3MO0
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E11
提交 2010-04-22
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
E11 N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6,7-dimethoxyquinazoline-2,4-diamine × 2
ZN ZINC ION × 5
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M HEPES, 18 20% (v/v) polyethylene glycol 4000 and 7 10% (v/v) isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.78 Å
R-free 0.306
|
|
3MO0
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E11
提交 2010-04-22
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
E11 N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6,7-dimethoxyquinazoline-2,4-diamine × 1
ZN ZINC ION × 5
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M HEPES, 18 20% (v/v) polyethylene glycol 4000 and 7 10% (v/v) isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.78 Å
R-free 0.306
|
|
3MO0
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E11
提交 2010-04-22
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
951–1235(285 aa)
片段:C-terminal SET domain
链 B
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
E11 N~4~-(1-benzylpiperidin-4-yl)-N~2~-[3-(dimethylamino)propyl]-6,7-dimethoxyquinazoline-2,4-diamine × 3
ZN ZINC ION × 10
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M HEPES, 18 20% (v/v) polyethylene glycol 4000 and 7 10% (v/v) isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.78 Å
R-free 0.306
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 4
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 4
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 C
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 4
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 1
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 4
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 D
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 4
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 1
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 5
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
951–1235(285 aa)
片段:C-terminal SET domain
链 B
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 8
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3MO5
Human G9a-like (GLP, also known as EHMT1) in complex with inhibitor E72
提交 2010-04-22
|
配体/离子不同
结构质量不同
|
Assembly 6
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
951–1235(285 aa)
片段:C-terminal SET domain
链 D
951–1235(285 aa)
片段:C-terminal SET domain
|
未记录
|
ZN ZINC ION × 8
E72 7-[(5-aminopentyl)oxy]-N~4~-[1-(5-aminopentyl)piperidin-4-yl]-N~2~-[3-(dimethylamino)propyl]-6-methoxyquinazoline-2,4-diamine × 2
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes pH 7.5, 14% polyethylene glycol 4000, 9% isopropanol, and 12% dimethyl sulfoxide, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.14 Å
R-free 0.233
|
|
3SW9
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me0 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 4
SFG SINEFUNGIN × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 3.05 Å
R-free 0.248
|
|
3SW9
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me0 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 4
SFG SINEFUNGIN × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 3.05 Å
R-free 0.248
|
|
3SW9
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me0 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 A
982–1266(285 aa)
片段:unp residues 982-1266
链 B
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 8
SFG SINEFUNGIN × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 3.05 Å
R-free 0.248
|
|
3SWC
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me2 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 4
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.33 Å
R-free 0.227
|
|
3SWC
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me2 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 4
SAH S-ADENOSYL-L-HOMOCYSTEINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.33 Å
R-free 0.227
|
|
3SWC
GLP (G9a-like protein) SET domain in complex with Dnmt3aK44me2 peptide
提交 2011-07-13
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 A
982–1266(285 aa)
片段:unp residues 982-1266
链 B
982–1266(285 aa)
片段:unp residues 982-1266
|
未记录
|
ZN ZINC ION × 8
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;0.1 M Hepes, 16% polyethylene glycol 4000 and 8% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
分辨率 2.33 Å
R-free 0.227
|
|
4I51
Methyltransferase domain of HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 1, mutant Y1211A
提交 2012-11-28
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 5
PDB 声明:pentameric
|
链 A
982–1266(285 aa)
链 B
982–1266(285 aa)
|
突变:Y1211A
突变:Y1211A
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
ZN ZINC ION × 8
GOL GLYCEROL × 3
UNX UNKNOWN LIGAND × 9
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 7.5;10% ISOPROPANOL, 20% PEG4000; 0.1M HEPES PH7.5, VAPOR DIFFUSION HANGING DROP, TEMPERATURE 297K
|
分辨率 1.90 Å
R-free 0.195
|
|
5TTG
Crystal structure of catalytic domain of GLP with MS012
提交 2016-11-03
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
982–1266(285 aa)
片段:UNP residues 879-1159
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 1
7KZ N4-(1-methylpiperidin-4-yl)-N2-hexyl-6,7-dimethoxyquinazoline-2,4-diamine × 1
ZN ZINC ION × 4
CL CHLORIDE ION × 1
GOL GLYCEROL × 1
UNX UNKNOWN LIGAND × 6
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.6;293 K;20% PEG 4000, 20% IProp, 0.1 M NaCitrate pH5.6
|
分辨率 1.66 Å
R-free 0.192
|
|
5TTG
Crystal structure of catalytic domain of GLP with MS012
提交 2016-11-03
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
982–1266(285 aa)
片段:UNP residues 879-1159
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 1
7KZ N4-(1-methylpiperidin-4-yl)-N2-hexyl-6,7-dimethoxyquinazoline-2,4-diamine × 1
ZN ZINC ION × 4
UNX UNKNOWN LIGAND × 9
DMS DIMETHYL SULFOXIDE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.6;293 K;20% PEG 4000, 20% IProp, 0.1 M NaCitrate pH5.6
|
分辨率 1.66 Å
R-free 0.192
|
|
5TUZ
Structure of human GLP SET-domain (EHMT1) in complex with inhibitor MS0124
提交 2016-11-07
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
片段:UNP residues 1006-1266
链 B
1006–1266(261 aa)
片段:UNP residues 1006-1266
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 2
ZN ZINC ION × 8
7L6 6,7-dimethoxy-N-(1-methylpiperidin-4-yl)-2-(morpholin-4-yl)quinazolin-4-amine × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 9;290 K;20% PEG 20,000, 2% (v/v) 1,4-Dioxane, 0.1 M Bicine (pH 9.0)
|
分辨率 1.95 Å
R-free 0.201
|
|
5V9J
Crystal structure of catalytic domain of GLP with MS0105
提交 2017-03-23
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
982–1266(285 aa)
片段:residues 982-1266
链 B
982–1266(285 aa)
片段:residues 982-1266
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 2
90P N~2~-cyclohexyl-N~4~-(1-ethylpiperidin-4-yl)-6,7-dimethoxy-N~2~-methylquinazoline-2,4-diamine × 2
ZN ZINC ION × 8
CL CHLORIDE ION × 3
UNX UNKNOWN LIGAND × 13
DMS DIMETHYL SULFOXIDE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.6;293 K;20% PEG 4000, 20% IProp, 0.1 M NaCitrate pH5.6
|
分辨率 1.74 Å
R-free 0.197
|
|
5VSD
Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 13
提交 2017-05-11
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
片段:GLP catalytic SET-domain residues 1006-1266
链 B
1006–1266(261 aa)
片段:GLP catalytic SET-domain residues 1006-1266
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 2
ZN ZINC ION × 8
9HJ 6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)-N~2~-propylquinazoline-2,4-diamine × 2
DIO 1,4-DIETHYLENE DIOXIDE × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 9;290 K;7 % PEG 20K, 1.4% v/v 1,4-Dioxane, 10% glycerol, 0.07 M Bicine, pH 9.0
|
分辨率 1.85 Å
R-free 0.235
|
|
5VSF
Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 17
提交 2017-05-11
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
片段:GLP catalytic SET-domain residues 1006-1266
链 B
1006–1266(261 aa)
片段:GLP catalytic SET-domain residues 1006-1266
|
未记录
|
SAM S-ADENOSYLMETHIONINE × 2
ZN ZINC ION × 8
9HG N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine × 2
DIO 1,4-DIETHYLENE DIOXIDE × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 9;290 K;10 % PEG 20K, 1.4% v/v 1,4-Dioxane, 10% glycerol, 0 0.1 M Bicine, pH 9.0
|
分辨率 1.70 Å
R-free 0.185
|
|
6BY9
Crystal structure of EHMT1
提交 2017-12-20
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
672–999(328 aa)
|
未记录
|
UNX UNKNOWN LIGAND × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1M BIS-TRIS pH6.5,3.0M NaCl
|
分辨率 2.30 Å
R-free 0.238
|
|
6MBO
GLP Methyltransferase with Inhibitor EML741-P212121 Crystal Form
提交 2018-08-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
链 B
1006–1266(261 aa)
|
未记录
|
JDG 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine × 4
ZN ZINC ION × 8
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
EDO 1,2-ETHANEDIOL × 14
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.5;292 K;15% PEG 4000, 20% isopropanol and 100mM citrate (pH 5.5)
|
分辨率 1.59 Å
R-free 0.194
|
|
6MBP
GLP Methyltransferase with Inhibitor EML741- P3121 Crystal Form
提交 2018-08-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
片段:residues 1006-1266
链 B
1006–1266(261 aa)
片段:residues 1006-1266
|
未记录
|
JDG 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine × 2
ZN ZINC ION × 8
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
EDO 1,2-ETHANEDIOL × 12
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.5;292 K;15% PEG 4000, 20% isopropanol and 100mM citrate (pH 5.5)
|
分辨率 1.95 Å
R-free 0.182
|
|
7T7M
Structure of human GLP SET-domain (EHMT1) in complex with covalent inhibitor (Compound 1)
提交 2021-12-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
982–1266(285 aa)
片段:residues 982-1266
链 D
982–1266(285 aa)
片段:residues 982-1266
|
未记录
|
ZN ZINC ION × 8
G4R N-(6-methoxy-4-{[1-(propan-2-yl)piperidin-4-yl]amino}-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-2-yl)prop-2-enamide × 1
G5U N-(6-methoxy-4-{[1-(propan-2-yl)piperidin-4-yl]amino}-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-2-yl)propanamide × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;290.15 K;0.2 Magnesium Formate, 15% w/v Polyethylene glycol 3350
|
分辨率 2.85 Å
R-free 0.244
|
|
7T7M
Structure of human GLP SET-domain (EHMT1) in complex with covalent inhibitor (Compound 1)
提交 2021-12-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
982–1266(285 aa)
片段:residues 982-1266
链 C
982–1266(285 aa)
片段:residues 982-1266
|
未记录
|
ZN ZINC ION × 8
G4R N-(6-methoxy-4-{[1-(propan-2-yl)piperidin-4-yl]amino}-7-[3-(pyrrolidin-1-yl)propoxy]quinazolin-2-yl)prop-2-enamide × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;290.15 K;0.2 Magnesium Formate, 15% w/v Polyethylene glycol 3350
|
分辨率 2.85 Å
R-free 0.244
|
|
8XPT
The Crystal Structure of EHMT1 from Biortus.
提交 2024-01-04
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
982–1266(285 aa)
链 C
982–1266(285 aa)
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
ZN ZINC ION × 8
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M Li2SO4, 0.1M Tris-HCl pH8.5, 25% PEG MME 5000
|
分辨率 3.35 Å
R-free 0.262
|
|
8XPT
The Crystal Structure of EHMT1 from Biortus.
提交 2024-01-04
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
982–1266(285 aa)
链 D
982–1266(285 aa)
|
未记录
|
SAH S-ADENOSYL-L-HOMOCYSTEINE × 2
ZN ZINC ION × 8
SO4 SULFATE ION × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M Li2SO4, 0.1M Tris-HCl pH8.5, 25% PEG MME 5000
|
分辨率 3.35 Å
R-free 0.262
|
|
9YKR
Crystal structure of the GLP (EHMT1) SET domain in complex with SAM and TNG917
提交 2025-10-07
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1006–1266(261 aa)
片段:catalytic SET domain (UNP residues 1006-1266)
链 B
1006–1266(261 aa)
片段:catalytic SET domain (UNP residues 1006-1266)
|
未记录
|
ZN ZINC ION × 8
SAM S-ADENOSYLMETHIONINE × 2
A1CXM N~2~-[(7M)-6-fluoro-7-(2,5,6,7-tetrahydro-1H-azepin-4-yl)-2,3-dihydro-1-benzofuran-5-yl]-N~4~,6-dimethylpyrimidine-2,4-diamine × 2
PEG DI(HYDROXYETHYL)ETHER × 4
SO4 SULFATE ION × 16
EDO 1,2-ETHANEDIOL × 21
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 5.5;298 K;30% PEG3350, 200 mM lithium sulfate, 100 mM Bis-Tris, pH 5.5
|
分辨率 1.38 Å
R-free 0.154
|